September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Effect of epigenetic regulation on fibrotic change in retinal pigment epithelium cells
Author Affiliations & Notes
  • Hiroki Hatanaka
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
  • Atsushi Mukai
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
  • Kazuhito Yoneda
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
  • Jun Yamada
    ophthalmology, Meiji University of Integrative Medicine, Nantan, Japan
  • Chie Sotozono
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
  • Shigeru Kinoshita
    Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Junji Hamuro
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
  • Footnotes
    Commercial Relationships   Hiroki Hatanaka, None; Atsushi Mukai, None; Kazuhito Yoneda, None; Jun Yamada, None; Chie Sotozono, None; Shigeru Kinoshita, None; Junji Hamuro, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6530. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Hiroki Hatanaka, Atsushi Mukai, Kazuhito Yoneda, Jun Yamada, Chie Sotozono, Shigeru Kinoshita, Junji Hamuro; Effect of epigenetic regulation on fibrotic change in retinal pigment epithelium cells. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6530.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Proliferative eye diseases such as proliferative vitreoretinopathy and proliferative diabetic retinopathy are a major cause of blindness. Age-related macular degeneration (AMD) is recently on the increase, and it causes central scotoma and severe reduced visual acuity through the progression of choroidal neovascularization and the formation of fibrin at the macula area. Fibroblastic change of retinal pigment epithelium (RPE) cells or the fibroblastic membrane is one of the major causes of proliferative eye diseases. The purpose of this present study was to examine the effect of histone deacetylase (HDAC) and histone acetyl transferase (HAT) on fibrotic change in RPE cells.

Methods : Following the method described in previous reports, ARPE-19 cells (5×105 cells/mm2) were cultured in10% fetal bovine serum (FBS) and then starved in serum-free medium for 24 hours. The culture medium was then replaced with fresh transforming growth factor beta 2 (TGF-β2, 30ng/ml) or/and tumor necrosis factor alpha (TNF-α, 10ng/ml) medium, and fibrotic change of the ARPE-19 cells was induced. Culture medium without TGF-β2 and TNF-α was used as a control. Cell morphology was examined by phase contrast microscopy after 48 hours of incubation. Simultaneously, the expression of α-smooth muscle actin (α-SMA), matrix metalloproteinase-9 (MMP-9), and CD44 were examined by immunostaining, western blotting, and polymerase chain reaction (PCR). The activity of HDAC and HAT were then observed between the following four groups: 1) control, 2) TGF-β2, 3) TNF-α, and 4) TGF-β2+TNF-α.

Results : Fibroblastic change of ARPE-19 cells was observed in all groups except for the control, and the potentiating effect of the change was noted in the medium with TGF-β2+TNF-α. The expression of α-SMA mRNA was enhanced by TGF-β2 (p<0.05), yet reduced by TNF-α or TGF-β2+TNF-α (p<0.01). The MMP-9 and CD44 mRNA expression was increased by TNF-α or TGF-β2+TNF-α (p<0.01). Similar trends were observed in immunostaining and western blotting. The activity of HAT was reduced by TNF-α or TGF-β2+TNF-α (p<0.05), and that of HDAC1 was significantly increased by TGF-β2+TNF-α (p<0.01).

Conclusions : Our findings indicate that alterations in the activity of HDAC and HAT are likely related to the fibroblastic change of RPE cells. We speculate that HDAC and HAT will become therapeutic targets for proliferative eye diseases and AMD.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×